Sinopharm
1099.HK
#1978
Rank
โ‚น713.07 B
Marketcap
โ‚น228.50
Share price
0.24%
Change (1 day)
4.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น6.936 Trillion. In 2022 the company made a revenue of โ‚น6.936 Trillion a decrease over the revenue in the year 2021 that were of โ‚น7.085 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.089 T-26.63%
2022 โ‚น6.936 T-2.1%
2021โ‚น7.085 T16.85%
2020โ‚น6.063 T14.95%
2019โ‚น5.274 T21.52%
2018โ‚น4.340 T5.93%
2017โ‚น4.097 T27.22%
2016โ‚น3.220 T5.37%
2015โ‚น3.056 T9.14%
2014โ‚น2.800 T17.22%
2013โ‚น2.389 T25.94%
2012โ‚น1.897 T34.61%
2011โ‚น1.409 T55.34%
2010โ‚น907.21 B35.79%
2009โ‚น668.11 B37.56%
2008โ‚น485.69 B31.43%
2007โ‚น369.55 B40.26%
2006โ‚น263.47 B